GSK Ebola Vaccine: Big pharma has an interest in rich people being sick


http://www.theguardian.com/commentisfree/belief/2014/oct/17/big-pharma-interest-rich-people-sick?CMP=fb_gu#start-of-comments

Big pharma has an interest in rich people being sick

What profit is there in a healthy population? If everyone were healthy, it would be the job of the pharmaceutical companies to persuade us that we were not well
A burial team with the body of an Ebola victim in Monrovia, Liberia. Photograph: Marcus DiPaola/NurP
A burial team with the body of an Ebola victim in Monrovia, Liberia. Photograph: Marcus DiPaola/NurPhoto/Rex

The giant pharmaceutical company GlaxoSmithKline said yesterday that its work on a vaccine for Ebola will “come too late” to do anything about the current situation. Even now it is trying to compress trials that would normally take a decade into a year. The impression it gives is that it is working flat out, no holds barred. But hang on a moment. Ebola was discovered back in 1976. What has GlaxoSmithKline been doing since then? Answer: not much.

A small clue to why can be found by looking at the stock price of Tekmira Pharmaceuticals, the Canadian-based drugs firm that some investors seem to think is leading the pack on Ebola research. Tekmira shares rose a massive 180% from mid-July to October, with most of the share-price action coming when the virus jumped to Europe and the US.

Ebola has been killing people in central and western Africa for at least 38 years – but it’s only when the virus becomes a threat to the developed world that there is seen to be a profit in it. I know it sounds cynical to say it flat out like that – but it sounds cynical because it is. What business case is there for developing drugs to save the lives of poor Africans when they don’t have the money to pay for them? Especially when there is so much more profit to be had in – for instance – giving rich white men erections. As a study in last year’s Lancet showed, of the 336 new drugs developed in the first decade of this century, only four of them were for what are known in jargon as neglected tropical diseases – three for malaria and one for diarrhoea.

The point being this: the business model of market-driven big (or even medium-sized) pharma does not work well to address the challenges posed by a virus that ultimately has no respect for geography or bank balance. Some of the developed world’s early interest in Ebola was in whether it could be weaponised. It was said that the Russian biological weapons unit – Biopreparat – had turned Ebola into an aerosol spray.

All of which is red meat for conspiracy theorists (like those who tell you that the patent for the Ebola virus is owned by the US government, which is true). But my suspicion is not about shady government actions but about basic capitalist economics. Isn’t it interesting that there is money about to ask scientists to turn a virus into a weapon, but not the money about to ask scientists to find a vaccine? And by the time there’s a market for a vaccine, it’s too late.

What better example of what is commonly called market failure – that state of affairs in which market forces do not make for desirable outcomes. Here’s another example: remember Nelson Mandela having to take on the big pharmaceutical companies as thousands of dying South Africans were unable to afford Aids drugs. Apparently, the market-driven economics of health care do not have an answer to a virus that begins in a part of the world where there isn’t much money. And that is often where dangerous viruses begin. Which is precisely why market forces will not be able to save us.

Indeed, on the contrary, market-driven healthcare is incentivised to keep us sick. For what profit is there in a healthy population? If everyone were healthy, it would be the job of the pharmaceutical companies to persuade us that we were not well, that certain things about us needed fixing, putting right (even if they didn’t).

Its a bit like Friedrich Nietzsche’s criticism of the Christian priest: that the priest first has to poison us into imagining we are unwell – and thus in need of saving – before he can present himself as the cure, as salvation. There is no market for salvation in a sinless world. Of course, big pharma presents itself as evidence-based and scientific. Not at all like Nietzsche’s Christianity. But it’s not the science that calls the tune. It is the stock price. And the stock price goes up when rich people feel threatened.

Ebola vaccine to be manufactured by criminal drug company (GSK) with felony record; rushed to market with near-zero safety testing


Ebola vaccine to be manufactured by criminal drug company with felony record; rushed to market with near-zero safety testing

Learn more: http://www.naturalnews.com/046414_Ebola_vaccine_safety_testing_drug_company_profits.html##ixzz3A7V1ETQi

 

Ebola vaccine to be manufactured by criminal drug company with felony record; rushed to market with near-zero safety testing

Monday, August 11, 2014

by Mike Adams, the Health Ranger

(NaturalNews) While the world of conventional medicine lines up to profit from the Ebola panic, there is no mention anywhere in the mainstream media of the criminal corporation behind the Ebola vaccine.

GlaxoSmithKline, now being celebrated by the pro-pharma press, is the same company that also has a proven criminal record of bribing physicians and knowingly distributing misleading information about the safety of their drug products.

Just two years ago, GSK plead guilty to felony crimes in the United States and was forced to pay an historical $3 billion fine for committing those crimes. After paying the fine, GSK was then exempted from normal rules regarding criminal enterprise, allowing it to continue conducting business with the federal government.

“Global health care giant GlaxoSmithKline LLC (GSK) agreed to plead guilty and to pay $3 billion to resolve its criminal and civil liability arising from the company’s unlawful promotion of certain prescription drugs, its failure to report certain safety data, and its civil liability for alleged false price reporting practices, the Justice Department announced today,” says a U.S. Department of Justice press release.

It goes on to explain, “GSK agreed to plead guilty to a three-count criminal information, including two counts of introducing misbranded drugs, Paxil and Wellbutrin, into interstate commerce and one count of failing to report safety data about the drug Avandia to the Food and Drug Administration (FDA).”

As Natural News reported in 2012:

A roughly nine-year federal investigation has exposed GSK’s rampant abuse of the law by illegally marketing drugs, forging drug safety data, bribing doctors to promote dangerous and expensive drugs, ripping off Medicare and Medicaid, and lying about the effectiveness and safety of drugs. And all this deception has generated tens of billions of dollars in profits for GSK over the years, while thousands of patients who used the drug products involved have suffered horrific side effects and even death.

Criminal drug company to spearhead Ebola vaccine with U.S. scientists

Now this same company that admitted committing multiple felony crimes is going to lead the development of the Ebola vaccine.

As CNBC reports: (1)

“A clinical trial of an experimental vaccine against the deadly Ebola virus is set to start shortly, according to British drugmaker GlaxoSmithKline, which is co-developing the product with U.S. scientists.”

Vaccine to be “rushed through” with very little safety testing

We also know that the vaccine will not be tested for anything other than short-term side effects. This is all part of the “rush to market” for Big Pharma to profit from Ebola as quickly as possible.

As CNBC says:

A company spokeswoman said on Sunday that the trial should get underway “later this year”, while GSK’s partner the U.S. National Institute of Allergy and Infectious Diseases (NIAID) said in a statement on its website it would start “as early as fall 2014”, implying a potential September launch of testing.

A headline in the Daily Mail declares “World Health Organisation says vaccine could be ‘rushed through’ for 2015.” (2)

That same story goes on to report, “the WHO said a potential vaccine for the Ebola virus is being tested on humans and could be ready for widespread use by early 2015.”

Doing the math here, if the Ebola vaccine clinical trials start in September of 2014 and the vaccine is manufactured and distributed to the public by “early 2015,” this leaves virtually zero time for observing vaccine side effects.

Manufacturing the vaccine in large quantities, after all, takes many months. If this vaccine is to be available to the public in early 2015, they will have to start manufacturing it as early as October 2014, roughly just one month after the vaccine trials begin.

Zero liability; total immunity for faulty products

Keep in mind that in the United States, vaccine manufacturers have zero liability for the damage and death caused by their products. Due to a literal Act of Congress, all vaccine manufacturers are able to abandon all safety testing and knowingly sell faulty, deadly products with zero risk of liability.

This was all set up by design to make sure vaccine manufacturers could enjoy record profits while having zero liability for producing faulty products that harm children and adults. This is the reason why mercury is still used in flu vaccines which are injected into children — a fact which I have scientifically proven in the Natural News Forensic Food Labs using ICP-MS instrumentation.

This total immunity means there is no incentive for adequate safety testing of an Ebola vaccine. The company has the same liability (zero) whether they test the vaccine or not. Their goal is to SELL the vaccine, not to make sure it’s safe and effective. Time spent on conducting rigorous clinical trials with long-term observations simply isn’t part of the “Sell! Sell! Sell!” business plan of today’s vaccine manufacturers. Their current business slogan? “Every pandemic is an opportunity for profit.” And with blanket immunity from all product liability, who needs safety testing?

Vaccine manufacturers routinely rely on scientific fraud

Here’s additional information you need to know about vaccine fraud, originally published in this article on Natural News:

According to two Merck scientists who filed a False Claims Act complaint in 2010 — a complaint which has just now been unsealed — vaccine manufacturer Merck knowingly falsified its mumps vaccine test data, spiked blood samples with animal antibodies, sold a vaccine that actually promoted mumps and measles outbreaks, and ripped off governments and consumers who bought the vaccine thinking it was “95% effective.”

See that False Claims Act document at:

http://www.naturalnews.com/gallery/documents…

According to Stephen Krahling and Joan Wlochowski, both former Merck virologists, the Merck company engaged in all the following behavior:

• Merck knowingly falsified its mumps vaccine test results to fabricate a “95% efficacy rate.”

• In order to do this, Merck spiked the blood test with animal antibodies in order to artificially inflate the appearance of immune system antibodies. As reported in CourthouseNews.com:

Merck also added animal antibodies to blood samples to achieve more favorable test results, though it knew that the human immune system would never produce such antibodies, and that the antibodies created a laboratory testing scenario that “did not in any way correspond to, correlate with, or represent real life … virus neutralization in vaccinated people,” according to the complaint.

• Merck then used the falsified trial results to swindle the U.S. government out of “hundreds of millions of dollars for a vaccine that does not provide adequate immunization.”

• Merck’s vaccine fraud has actually contributed to the continuation of mumps across America, causing more children to become infected with mumps.

• Merck used its false claims of “95 percent effectiveness” to monopolize the vaccine market and eliminate possible competitors.

• The Merck vaccine fraud has been going on since the late 1990’s, say the Merck virologists.

• Testing of Merck’s vaccine was never done against “real-world” mumps viruses in the wild. Instead, test results were simply falsified to achieve the desired outcome.

• This entire fraud took place “with the knowledge, authority and approval of Merck’s senior management.”

• Merck scientists “witnessed firsthand the improper testing and data falsification in which Merck engaged to artificially inflate the vaccine’s efficacy findings,” according to court documents.

Sources for this article include:

(1) http://www.cnbc.com/id/101909486

(2) http://www.dailymail.co.uk/news/article-2721…

(3) http://www.justice.gov/opa/pr/2012/July/12-c…

Learn more: http://www.naturalnews.com/046414_Ebola_vaccine_safety_testing_drug_company_profits.html##ixzz3A7VDufRW